Stock-Based Compensation (Tables)

3 Months Ended

Sep. 30, 2013

Stock Settled Stock Appreciation Rights SARS [Member]

The following table summarizes information relating to the 2014 grant:



	2014
SSSARs granted	2
Weighted average grant date fair value per right	$	10.14
Assumptions used in fair value calculations:
Risk-free interest rate	0.61		%
Dividend yield	2.01		%
Volatility factor of the expected market price of our common stock	23.00		%
Weighted average expected life in years	2.68
Estimated forfeiture rate	—		%

The following table summarizes SSSARs compensation expense and tax benefits recorded:



	Three Months Ended September 30,
	2013		2012
Compensation expense	$	307	$	461
Tax benefits	$	107	$	161
Intrinsic value of exercises	$	18	$	690
Gross windfall tax benefits	$	6	$	241

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the three months ended September 30, 2013:



	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of period	374		$	66.42
Exercised	(2	)	$	61.80
Granted	2		$	79.78
Forfeited	—		$	—
Outstanding at end of period	374		$	66.51	3.27	$	4,408
Exercisable and vested at end of period	110		$	60.87	2.21	$	1,910
Vested and expected to vest at end of period	365		$	66.51	3.27	$	4,302

Restricted Stocks [Member]

The following table summarizes restricted stock compensation expense and tax benefits recorded:



	Three Months Ended September 30,
	2013		2012
Compensation expense	$	340	$	410
Tax benefits	$	119	$	144
Gross windfall tax benefits	$	2	$	1

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the three months ended September 30, 2013:



	Number of Shares	Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of period	45	$	68.16
Granted	—	$	—
Vested	—	$	—
Forfeited	—	$	—
Unvested restricted stock at end of period	45	$	68.21